Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Milstien

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Vaccine|October 24, 2001
Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick testD Xing, R G Das, T O'Neill, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 11, 1999
Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?B Blomberg, M E Kitler, J Milstien, et al.
In Vitro|June 1, 1979
Characterization of the WIDR: a human colon carcinoma cell lineP Noguchi, R Wallace, J Johnson, et al.
Alternatives to Laboratory Animals : ATLA|June 5, 2015
Validation of alternative methods for the potency testing of vaccinesC Hendriksen, J M Spieser, A Akkermans, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Vaccine|October 24, 2001
Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick testD Xing, R G Das, T O'Neill, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 11, 1999
Availability of quality fixed-dose combinations for the treatment of tuberculosis: what can we learn from studying the World Health Organization's vaccine model?B Blomberg, M E Kitler, J Milstien, et al.
In Vitro|June 1, 1979
Characterization of the WIDR: a human colon carcinoma cell lineP Noguchi, R Wallace, J Johnson, et al.
Alternatives to Laboratory Animals : ATLA|June 5, 2015
Validation of alternative methods for the potency testing of vaccinesC Hendriksen, J M Spieser, A Akkermans, et al.
Pageof 2